BIA Presses New UK Government On No-Deal Brexit Preparations
Executive Summary
The life sciences industry has given a cautious welcome to the prime minister’s promises that the sector will be a priority once the UK leaves the EU, but has urged the new UK government to take steps to protect medicine supply chains in the event of a no-deal Brexit.
You may also be interested in...
How Will You Spend Extra £434m On No-Deal Brexit Planning? Industry Asks UK Gov’t
BioIndustry Association wants more information about the UK government’s latest £2.1bn investment to fund preparations for a no-deal Brexit.
Brexit Stakes Rise As New UK Prime Minister Takes Over
The UK has a new prime minister in Boris Johnson, who is likely to surround himself with strongly pro-Brexit ministers. The life sciences industry will need to continue lobbying for its interests to be protected in the event of a no-deal exit.
UK Explains New Rules On Parallel Imports From EU
Guidance from the Medicines and Healthcare products Regulatory Agency says that the packaging of parallel imported medicines must make clear that they are for the UK market only.